Page last updated: 2024-09-05

tak 779 and cenicriviroc

tak 779 has been researched along with cenicriviroc in 2 studies

Compound Research Comparison

Studies
(tak 779)
Trials
(tak 779)
Recent Studies (post-2010)
(tak 779)
Studies
(cenicriviroc)
Trials
(cenicriviroc)
Recent Studies (post-2010) (cenicriviroc)
118135521246

Protein Interaction Comparison

ProteinTaxonomytak 779 (IC50)cenicriviroc (IC50)
C-C chemokine receptor type 7Homo sapiens (human)0.0031
C-C chemokine receptor type 2Homo sapiens (human)0.0059
C-C chemokine receptor type 5Homo sapiens (human)0.003
C-C chemokine receptor type 5Mus musculus (house mouse)0.0003

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Horuk, R; Pease, J1
Fenaux, M; Halcomb, RL; Jones, CT; Romero, FA; Xu, Y1

Reviews

1 review(s) available for tak 779 and cenicriviroc

ArticleYear
The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease.
    Journal of medicinal chemistry, 2020, 05-28, Volume: 63, Issue:10

    Topics: Animals; Anticholesteremic Agents; Drug Delivery Systems; Drug Development; Humans; Hypoglycemic Agents; Lipid Metabolism; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; PPAR gamma; Protein Structure, Tertiary

2020

Other Studies

1 other study(ies) available for tak 779 and cenicriviroc

ArticleYear
Chemokine receptor antagonists.
    Journal of medicinal chemistry, 2012, Nov-26, Volume: 55, Issue:22

    Topics: Animals; Autoimmune Diseases; Humans; Receptors, Chemokine

2012